ライフサイエンスコーパス: cardiac arrest

1 ent in comatose survivors of out-of-hospital cardiac arrest.

2 table angina, heart failure, or resuscitated cardiac arrest.

3 on, extracorporeal membrane oxygenation, and cardiac arrest.

4 of hospital patients at risk for developing cardiac arrest.

5 rt addresses the concept of autoimmunity and cardiac arrest.

6 longation, ventricular tachy-arrhythmias and cardiac arrest.

7 tion/ventricular tachycardia out-of-hospital cardiac arrest.

8 ion may improve outcome from out-of-hospital cardiac arrest.

9 xia or ischemia due to low cardiac output or cardiac arrest.

10 parents/caregivers of children who survived cardiac arrest.

11 ry as a consequence of cardiogenic shock and cardiac arrest.

12 etrograde amnesia covering ~5 y prior to the cardiac arrest.

13 e (MAP) in patients with AMI and shock after cardiac arrest.

14 electric EEG, which precedes respiratory and cardiac arrest.

15 od with reduced signal noise after pediatric cardiac arrest.

16 table angina, heart failure, or resuscitated cardiac arrest.

17 tion with hypotension, cardiogenic shock, or cardiac arrest.

18 rporeal cardiopulmonary resuscitation during cardiac arrest.

19 ions, could improve outcomes in survivors of cardiac arrest.

20 rk with which to compare systems of care for cardiac arrest.

21 nterventions delivered to patients following cardiac arrest.

22 m was recorded during the first 3 days after cardiac arrest.

23 tent coma after resuscitated out-of-hospital cardiac arrest.

24 ssure would improve neurologic outcome after cardiac arrest.

25 ients with cardiac diagnoses and in-hospital cardiac arrest.

26 included consecutive, comatose survivors of cardiac arrest.

27 sociated with confidence in resuscitation of cardiac arrest.

28 atures predict neurologic recovery following cardiac arrest.

29 neurological consequences occurring after a cardiac arrest.

30 sequent pulselessness, and initial pulseless cardiac arrest.

31 dysfunction limits neurologic recovery after cardiac arrest.

32 survival with good neurologic outcome after cardiac arrest.

33 imit of autoregulation in patients following cardiac arrest.

34 ximately half of all comatose patients after cardiac arrest.

35 mparison with placebo during out-of-hospital cardiac arrest.

36 opportunity to improve survival from sudden cardiac arrest.

37 al releasing system after resuscitation from cardiac arrest.

38 with known cardiac risk factors) had a fatal cardiac arrest.

39 process of care for patients who have had a cardiac arrest.

40 ent with infectious disease consultants, and cardiac arrest.

41 R delivery and survival from out-of-hospital cardiac arrest.

42 rowning, and harm from CPR to victims not in cardiac arrest.

43 , Medicare beneficiaries, and lower rates of cardiac arrest.

44 ody screening was performed in patients with cardiac arrest.

45 in the chain of survival for out-of-hospital cardiac arrest.

46 eath, disabling stroke, serious bleeding, or cardiac arrest.

47 s are assessed between 6 and 12 months after cardiac arrest.

48 in function and calculation of changes after cardiac arrest.

49 n unexpected and unsuccessfully resuscitated cardiac arrest.

50 evation myocardial infarction, and 43.3% had cardiac arrest.

51 antibody signature specific to patients with cardiac arrest.

52 were cardiovascular (21 of 33), including 15 cardiac arrests.

53 and poor perfusion and those with pulseless cardiac arrests.

54 D implantation, ventricular arrhythmias, and cardiac arrest: 0.96% (95% CI: 0.77% to 1.18%) for sarco

55 Common complications were arrhythmias (19%), cardiac arrest (10%), sepsis (7%), and acute renal failu

56 racorporeal membrane oxygenation (88%) (nine cardiac arrest; 13 cardiogenic shock) and three had veno

57 y complication (3.1-fold, 95% CI 2.94-3.36), cardiac arrest (3.0-fold, 95% CI 2.64-3.46), myocardial

58 rsus 78.7%), acute noncardiac organ failure, cardiac arrest (34.3% versus 35.7%), and received less-f

59 cardiac defibrillator discharge, and sudden cardiac arrest, 43%).

60 3 were male (63%), 3,019 had out-of-hospital cardiac arrest (48%), and 2,289 had initial shockable he

61 ontaneous circulation) from 39 patients with cardiac arrest, 5 with myocardial infarction, and 10 hea

62 ; 53.9% vs 26.2%; P = .002), postreperfusion cardiac arrest (7.7% vs 0.3%; P < .001), primary nonfunc

63 es (eg, age, initial rhythm, duration of the cardiac arrest), a multifaceted approach considering bot

64 levant ventricular arrhythmias, resuscitated cardiac arrest, acute kidney failure, and corrected QT i

65 hms as well as EMS-witnessed and unwitnessed cardiac arrests all had a significant association betwee

66 ndpoint was MACE, including all-cause death, cardiac arrest, AMI, cardiogenic shock, sustained ventri

67 nal injury in the brain caused by stroke and cardiac arrest among other diseases including pain, infl

68 not evolve to BD, 4 died after an unexpected cardiac arrest and 18 after the withdrawal of life-susta

69 A total of 7433 patients with a pulseless cardiac arrest and 5751 patients with a nonpulseless eve

70 Secondary outcomes were cardiac arrest and abnormal electrocardiogram findings (

71 al', which includes immediate recognition of cardiac arrest and activation of the emergency response

72 y (SPK) grafts from donors with a history of cardiac arrest and cardiopulmonary resuscitation (CACPR)

73 ally ill adults and may increase the risk of cardiac arrest and death.

74 During surgery, the patient experienced cardiac arrest and died despite immediate resuscitation.

75 supported by international guidelines (adult cardiac arrest and hypoxic-ischemic encephalopathy of ne

76 indicated by international guidelines (adult cardiac arrest and hypoxic-ischemic encephalopathy of ne

77 t outcomes due to organ hypoperfusion during cardiac arrest and mechanical trauma during resuscitatio

78 eased in 10 minutes versus 5 minutes no-flow cardiac arrest and naive controls.

79 were performed for patients with a pulseless cardiac arrest and patients with a nonpulseless event (b

80 uited to image patients in extremis-those in cardiac arrest and periarrest states.

81 with prevention and early identification of cardiac arrest and proceeding through resuscitation to p

82 e first opportunity to identify a patient in cardiac arrest and provide initial care by delivering CP

83 rial extracorporeal membrane oxygenation for cardiac arrest and refractory cardiogenic shock.

84 ide, Oxygen and Mean Arterial Pressure After Cardiac Arrest and Resuscitation; NCT02698917) trials wh

85 elate with brain injury severity early after cardiac arrest and return of spontaneous circulation.

86 One patient experienced cardiac arrest and three non-sustained ventricular tachy

87 90-day mortality in patients with witnessed cardiac arrest and with greater than or equal to 1 minut

88 There are ~292 000 adult in-hospital cardiac arrests and 15 200 pediatric in-hospital events

89 on interval, 4400-9900) cases were pulseless cardiac arrests and 8100 (95% prediction interval, 4700-

90 Because cardiac arrhythmias underlie most cardiac arrests and increasing evidence strongly support

91 ulted from two separate factors: the initial cardiac arrest (and respiratory distress) and the recurr

92 t 5-year follow-up: SCD, resuscitated sudden cardiac arrest, and aborted SCD, that is, appropriate sh

93 y limiting use of TRI (renal failure, shock, cardiac arrest, and mechanical circulatory support) were

94 are common among patients who have survived cardiac arrest, and often go unrecognised despite being

95 l cardiopulmonary resuscitation in pediatric cardiac arrest, and pediatric targeted temperature manag

96 d of a composite of cardiac syncope, aborted cardiac arrest, and sudden cardiac death, but a 38.8-fol

97 ioverter-defibrillator therapy, resuscitated cardiac arrest, and sustained ventricular tachycardia).

98 nts was 9.1% (14 SCD, 25 resuscitated sudden cardiac arrests, and 14 aborted SCD).

99 Continuous EEG patterns at 12 hours after cardiac arrest are associated with good recovery.

100 Germane to in-hospital cardiac arrest are recommendations about the recognition

101 evascularization procedures, or resuscitated cardiac arrest) assessed using measures of model discrim

102 B.), who developed memory impairment after a cardiac arrest at age 39.

103 l benefit in select patients with refractory cardiac arrest but there is insufficient data on the fre

104 Survivors of prolonged (>2 weeks) post-cardiac arrest (CA) coma are expected to remain permanen

105 Cardiac arrest (CA) is a leading cause of death and ther

106 Cardiac arrest (CA) may occur due to a variety of causes

107 y in each SCAI shock stage was stratified by cardiac arrest (CA).

108 b plus lenalidomide and dexamethasone group (cardiac arrest, cardiac failure, myocarditis, large inte

109 d metabolism during ventricular fibrillation cardiac arrest, cardiopulmonary resuscitation, and epine

110 s unknown whether certain characteristics of cardiac arrest care and outcomes of IHCAs during the COV

111 provide opportunities to improve in-hospital cardiac arrest care at other hospitals.

112 Further study is needed on cardiac arrest care in patients with COVID-19.

113 and proceeding through resuscitation to post-cardiac arrest care.

114 ergency medical services and integrated post-cardiac arrest care.

115 targeted temperature management during post-cardiac arrest care.

116 re compared with those from 22 patients with cardiac arrest cases of ischemic origin and a group of 2

117 rdiography for intra-arrest prognostication, cardiac arrest caused by pulmonary embolism, postresusci

118 linical debriefing, transport to specialized cardiac arrest centers, organ donation, and performance

119 entation and performance in communities, and cardiac arrest centers; advanced life support training,

120 upon carbon monoxide treatment, whereas post-cardiac arrest cerebral perfusion differences were dimin

121 first responders and a critical link in the cardiac arrest chain of survival.

122 After adjustment for demographic and cardiac arrest characteristics, targeted temperature man

123 n traumatic brain injury and anoxo-ischemic (cardiac arrest) coma patients by using an original multi

124 sociated with improved survival after sudden cardiac arrest, contrary to PCI of stable lesions.

125 Donor pigs underwent hypoxic cardiac arrest (DCD) followed by 15 minutes of warm isch

126 he durvalumab plus platinum-etoposide group (cardiac arrest, dehydration, hepatotoxicity, interstitia

127 ever, their rate of progression to pulseless cardiac arrest despite CPR and the differences in surviv

128 uscitated after experiencing out-of-hospital cardiac arrest, discharge survival was significantly low

129 y of cases, individuals with out-of-hospital cardiac arrest do not receive lay rescuer CPR and wait f

130 By multivariable analysis-adjusting for cardiac arrest duration, Sequential Organ Failure Assess

131 is higher rates of PRS, PNF, postreperfusion cardiac arrest, EAD, and AKI should be anticipated.

132 d OHCAs, of which 438 (53.5%) were confirmed cardiac arrests eligible for inclusion.

133 ccessfully resuscitated from out-of-hospital cardiac arrest enrolled in the CCC trial (Trial of Conti

134 evere tracheal intubation-associated events (cardiac arrest, esophageal intubation with delayed recog

135 ry about making errors during an in-hospital cardiac arrest event than nurses (18%; p < 0.001).

136 ted in less than or equal to six in-hospital cardiac arrest events per year, and 41% of respondents w

137 patients with refractory cardiogenic shock (cardiac arrest excluded) who required venoarterial extra

138 for advanced airway management in pediatric cardiac arrest, extracorporeal cardiopulmonary resuscita

139 12, or 16-minute potassium chloride-induced cardiac arrest followed by 90 seconds of cardiopulmonary

140 om 84 089 adult patients with an in-hospital cardiac arrest from 166 hospitals with continuous partic

141 prove overall survival after out-of-hospital cardiac arrest from shock-refractory ventricular fibrill

142 we compared a primary composite end point of cardiac arrest from ventricular tachycardia/fibrillation

143 ardized survival rate (RSSR) for in-hospital cardiac arrest has emerged as an important metric to ben

144 Prescribing patterns during in-hospital cardiac arrest have changed significantly over time.

145 mes of patients experiencing out-of-hospital cardiac arrest have demonstrated that, despite a higher

146 myocardial infarction, stroke, resuscitated cardiac arrest, heart failure, or revascularization.

147 assessed at 3 months and beyond 1 year after cardiac arrest if resources are available.

148 l obesity and outcomes following in-hospital cardiac arrest (IHCA).

149 ID-19) infection are at risk for in-hospital cardiac arrest (IHCA).

150 ents like resuscitation care for in-hospital cardiac arrest (IHCA).

151 ocess measures or outcomes after in-hospital cardiac arrest (IHCA).

152 atients, with ventricular tachycardia and/or cardiac arrest in 3 patients.

153 a prospective registry enrolling all sudden cardiac arrest in Paris and suburbs (6.7 million inhabit

154 in a multivariable analysis, out-of-hospital cardiac arrest in predominantly Hispanic neighborhoods h

155 Individuals with out-of-hospital cardiac arrest in predominantly Hispanic neighborhoods w

156 for patients presenting with out-of-hospital cardiac arrest in states with public reporting versus wi

157 us adverse event occurred in each group (one cardiac arrest in the control group and one episode of a

158 6, we identified patients who had refractory cardiac arrest in the ED.

159 The average annual incidence of in-hospital cardiac arrest in the United States was estimated at 292

160 ood functional outcome after out-of-hospital cardiac arrest in this cohort, this association is prima

161 ng severe cardiovascular symptoms (including cardiac arrest) in VIA and non-VIA cases.

162 en translated to clinical care for pediatric cardiac arrest, in part because signal noise causes high

163 eties who care for successfully resuscitated cardiac arrest individuals.

164 d patients, 36 (31.6%) screened positive for cardiac arrest-induced posttraumatic stress symptomatolo

165 Low cardiac output and cardiac arrest, inflammation-related organ failures, and

166 ymptomatology at discharge (median 21 d post cardiac arrest; interquartile range, 11-36).

167 Among patients experiencing out-of-hospital cardiac arrest, intra-arrest transport to hospital compa

168 Sudden cardiac arrest is a malfunction of the heart's electrica

169 Cardiac arrest is a tragic event that causes 1 death rou

170 In-hospital cardiac arrest is common and associated with a high mort

171 ing cardiopulmonary resuscitation for sudden cardiac arrest is common, occurring even in the absence

172 ity of cardiogenic shock following asystolic cardiac arrest is dependent on the length of cardiac arr

173 esult, the number of people surviving sudden cardiac arrest is increasing.

174 lin G purified from patients with idiopathic cardiac arrest is proarrhythmogenic by reducing the acti

175 Sudden cardiac arrest is the unexpected loss of heart function,

176 phy after resuscitation from out-of-hospital cardiac arrest is uncertain for patients without ST-segm

177 ognitive, and emotional effects of surviving cardiac arrest may linger for months or years.

178 rdinal severity score (worst to best: death, cardiac arrest, mechanical ventilation with mechanical c

179 use of a number of commonly used in-hospital cardiac arrest medications.

180 atients after ventricular arrhythmia-induced cardiac arrest (n=155).

181 An estimated 290 000 in-hospital cardiac arrests occur each year in the United States.

182 Out-of-hospital cardiac arrest occurred in 12% (n = 9) of the patients.

183 artile range, 55-80), 37% were women, 86% of cardiac arrests occurred in a private location, 49% were

184 Among 9265 sudden cardiac arrests occurring during the study period, 1078

185 In-hospital cardiac arrest occurs in over 290 000 adults each year i

186 Among patients with out-of-hospital cardiac arrest (OHCA) and ventricular fibrillation, more

187 ber of DALY because of adult out-of-hospital cardiac arrest (OHCA) in the United States is unknown.

188 transport to hospital during out-of-hospital cardiac arrest (OHCA) resuscitative efforts.

189 ms of care for patients with out-of-hospital cardiac arrest (OHCA), as little evidence exists to guid

190 (CPR) and defibrillation in out-of-hospital cardiac arrest (OHCA).

191 ween clinical parameters and out-of-hospital cardiac arrest (OHCA).

192 ocations improve coverage of out-of-hospital cardiac arrests (OHCAs).

193 n complete remission from sepsis (two [3%]), cardiac arrest (one [1%]), therapy-related acute myeloid

194 68 piglets were randomized to cardiac arrest or sham procedure with continuous monitor

195 can assess myocardial physiology and predict cardiac arrest outcomes, making these measures a candida

196 e United States, >350 000 people have sudden cardiac arrest outside of a hospital environment.

197 c support did not increase the risk of a new cardiac arrest (p = 0.88) or atrial fibrillation (p = 0.

198 ntly identified as a biomarker of idiopathic cardiac arrest (P=0.002; false discovery rate, 0.007; cl

199 , mechanical ventilation, mental status, and cardiac arrest parameters of the PBS were independent ri

200 ne, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest) participants.

201 In-hospital cardiac arrest participation frequency was the dominant

202 Confidence in in-hospital cardiac arrest participation was high overall (92%), but

203 ous coronary intervention (PCI) after sudden cardiac arrest, particularly in the absence of ST-segmen

204 t on the survival rate among out-of-hospital cardiac arrest patients (OHCA) is not well studied.

205 t not neurologic outcomes in out-of-hospital cardiac arrest patients compared with placebo.

206 ARTICIPANTS (SUBJECTS): We enrolled 41 adult cardiac arrest patients in whom blood could be obtained

207 Cardiac arrest patients showed specific structural distu

208 Of 782 out-of-hospital cardiac arrest patients transported to the study hospita

209 Comatose, adult out-of-hospital cardiac arrest patients treated during the targeted temp

210 y used patient-level pooled analysis of post-cardiac arrest patients with shock after AMI randomized

211 In post-cardiac arrest patients with shock after AMI, targeting

212 ibrillation shocks from 1151 out-of-hospital cardiac arrest patients.

213 and neurologic injury in intensive care and cardiac arrest patients; however, few studies have inves

214 al Directed Hemodynamic Optimization in Post-cardiac Arrest Patients; NCT02541591) and COMACARE (Carb

215 ion and clinical decision-making in the post-cardiac arrest period.

216 osseous route for drug administration during cardiac arrest, point-of-care echocardiography for intra

217 One (2%) patient died from cardiac arrest, possibly treatment related.

218 Initial interdisciplinary training in cardiac arrest prevention followed by clinical practice

219 round appropriate use of mechanical support, cardiac arrest prevention, and optimal heart transplanta

220 cardiac arrest is dependent on the length of cardiac arrest prior to cardiopulmonary resuscitation an

221 rdiac arrest, we discovered that duration of cardiac arrest prior to cardiopulmonary resuscitation de

222 the public health impact of out-of-hospital cardiac arrest, provides guidance and resources to const

223 time series analysis was used to compare the cardiac arrest rate in the 18 months before and 4.5 year

224 In the time series analysis, monthly cardiac arrest rate in the ICU decreased by 12.4 per 1,0

225 Mean monthly cardiac arrest rate was 17.2 per 1,000 patient days befo

226 to a significant, sustained reduction in ICU cardiac arrest rate.

227 er was arrhythmic death (AD) or resuscitated cardiac arrest (RCA).

228 Women who suffer an out-of-hospital cardiac arrest receive bystander cardiopulmonary resusci

229 tions about community initiatives to promote cardiac arrest recognition, cardiopulmonary resuscitatio

230 However, 5% to 10% of cardiac arrests remain unexplained.

231 Neurologic damage following cardiac arrest remains a major burden for modern resusci

232 Efforts to prevent in-hospital cardiac arrest require both a system for identifying det

233 Survival after out-of-hospital cardiac arrest requires an integrated system of care (ch

234 Survival after cardiac arrest requires an integrated system of people,

235 both confident participating in in-hospital cardiac arrest resuscitation and did not worry about mak

236 re most likely to participate in in-hospital cardiac arrest resuscitation at a community, rural, or c

237 transthoracic echocardiography (TTE) during cardiac arrest resuscitation can enable the characteriza

238 tial, practical therapy for improving sudden cardiac arrest resuscitation outcomes.

239 luating clinician perceptions of in-hospital cardiac arrest resuscitation participation was developed

240 This document expands the cardiac arrest resuscitation system of care to include p

241 luate and optimize the use of epinephrine in cardiac arrest resuscitation, particularly the dose, tim

242 e leading or participating in an in-hospital cardiac arrest resuscitation.

243 linicians' sentiments about participating in cardiac arrest resuscitations and identify factors assoc

244 ion analysis identified initial nonshockable cardiac arrest rhythm (odds ratio, 12.2; 95% CI, 2.83-52

245 d survival after adjustment for age, gender, cardiac arrest rhythm, witnessed status, bystander cardi

246 harge in the subgroup with shockable initial cardiac arrest rhythms.

247 n 2, and our previously developed electronic Cardiac Arrest Risk Triage score were compared for predi

248 ed disease (CID) causing resuscitated sudden cardiac arrest (RSCA) on a population basis is unknown.

249 serious arrhythmogenic endpoints like sudden cardiac arrest (SCA) or ventricular arrhythmia (VA).

250 al (n=32, 20%) symptoms and following sudden cardiac arrest/shock (n=5, 3%).

251 However, the rate of cardiac arrests significantly dropped from 5.3 to 2.1 pe

252 nrolled, interventions that were part of the cardiac arrest structured care pathway, and outcomes.

253 Sprague-Dawley rats were used in asphyxial cardiac arrest studies.

254 ddition of recovery as an important stage in cardiac arrest survival.

255 For pulseless cardiac arrests, survival was 19% (95% CI, 11%-29%) in 2

256 eported outcomes of clinical trials of adult cardiac arrest survivors and supported this P-COSCA init

257 Most of the poor outcomes and deaths of cardiac arrest survivors have been attributed to widespr

258 ologic outcome prediction in out-of-hospital cardiac arrest survivors is highly limited due to the la

259 atients with acute cardiovascular events and cardiac arrest survivors, testing for primary and second

260 ome and contribute to the quality of life of cardiac arrest survivors.

261 f poor neurologic outcome in out-of-hospital cardiac arrest survivors.

262 ealthcare partnerships, which are central to cardiac arrest survivorship.

263 lmonary resuscitation with a Lund University Cardiac Arrest System, and estimated transfer time short

264 Cardiac arrest systems of care are successfully coordina

265 ould consider methods to provide in-hospital cardiac arrest teams additional "effective experience,"

266 More patients are surviving cardiac arrest than ever before; however, the burden now

267 n of spontaneous circulation for in-hospital cardiac arrest than nonaward hospitals (median [interqua

268 versus 54.9%), and had a lower proportion of cardiac arrests that were witnessed (55.1% versus 64.5%)

269 rlying characteristics, steroid use prior to cardiac arrest, the vasopressors, and shockable rhythm d

270 Specific to out-of-hospital cardiac arrest, this Part contains recommendations about

271 m of the study was to evaluate the effect of cardiac arrest time (CAT) in donors after brain death (D

272 7 hours (15-88 hr), and median duration from cardiac arrest to inclusion was 15 hours (6-44 hr).

273 the COSCA initiative (Core Outcome Set After Cardiac Arrest) to improve consistency in reported outco

274 tion/ventricular tachycardia out-of-hospital cardiac arrest treated with the University of Minnesota

275 Comorbidities, junior operator, cardiac arrest upon admission, and coma were associated

276 Studies of pediatric cardiac arrest use inconsistent outcomes, including retu

277 the following topics: dispatch diagnosis of cardiac arrest, use of a firm surface for CPR, sequence

278 neurologic outcome at 12 and 24 hours after cardiac arrest using electroencephalogram epochs and out

279 delivery and survival after out-of-hospital cardiac arrest vary at the neighborhood level, with lowe

280 Cardiac arrest was a risk factor for CVC-related thrombo

281 The most common etiology of cardiac arrest was acute coronary syndrome (n = 1,657, 5

282 rter-defibrillator intervention, and aborted cardiac arrest was considered.

283 the initial 6 hours after resuscitation from cardiac arrest was independently associated with good ne

284 Cardiac arrest was observed in 5 probands (age 15.3 +/-

285 ompared with patients receiving neither drug cardiac arrest was significantly more likely in patients

286 Using a murine model of asystolic cardiac arrest, we discovered that duration of cardiac a

287 k of hypoxic ischemic brain injury following cardiac arrest, we sought to: 1) characterize brain oxyg

288 ma samples from 23 patients with unexplained cardiac arrest were compared with those from 22 patients

289 ion after resuscitation from out-of-hospital cardiac arrest were prospectively randomized in a 1:1 fa

290 by initial cardiac rhythm and EMS-witnessed cardiac arrests were analyzed.

291 e to haemophagocytic lymphohistiocytosis and cardiac arrest) were previously reported, but no new tre

292 Innovative digital tools for recognizing cardiac arrest where and when it occurs, notifying poten

293 less ventricular tachycardia out-of-hospital cardiac arrest who were randomly assigned by emergency m

294 re management strategy after out-of-hospital cardiac arrest with initial shockable rhythm resulted in

295 nts with coma who had been resuscitated from cardiac arrest with nonshockable rhythm, moderate therap

296 ive care unit (ICU) after resuscitation from cardiac arrest with nonshockable rhythm.

297 esearch agenda for the use of focused TEE in cardiac arrest with the goal to improve resuscitation ou

298 increased vasopressor 32 [19%] vs 31 [18%], cardiac arrest within 1 h seven [4%] vs two [1%], death

299 l, we randomly assigned 552 patients who had cardiac arrest without signs of STEMI to undergo immedia

300 ronary angiography for comatose survivors of cardiac arrest without ST elevation.

301 n resuscitated patients with out-of-hospital cardiac arrest without ST-segment elevation.